openPR Logo
Press release

Global Molecular Oncology Diagnostics Market to Surpass $6.19 Billion by 2033, Driven by Precision Medicine

07-17-2025 05:30 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

The global molecular oncology diagnostics market is experiencing strong growth. With 2023 as the base year, the market size is estimated at $2,410.9 million in 2024 and is projected to reach $6,195.1 million by 2033, registering a CAGR of 11.06% during th

The global molecular oncology diagnostics market is experiencing strong growth. With 2023 as the base year, the market size is estimated at $2,410.9 million in 2024 and is projected to reach $6,195.1 million by 2033, registering a CAGR of 11.06% during th

The global molecular oncology diagnostics market, valued at $2,410.9 million in 2024, is projected to reach $6,195.1 million by 2033, growing at a CAGR of 11.06%. This growth is driven by the rise of precision medicine, rapid adoption of liquid biopsy and NGS technologies, and increased demand for companion diagnostics. North America leads the market, while AsiaPacific is expected to grow fastest.
BIS Research, a leading provider of market intelligence on transformative technologies, announces the release of its latest comprehensive study, "Global Molecular Oncology Diagnostics Market [https://bisresearch.com/industry-report/molecular-oncology-diagnostics-market.html?utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr] - Analysis and Forecast, 2024-2033."According to the report, the global molecular oncology diagnostics market was valued at $2,410.9 million in 2024 and is projected to reach $6,195.1 million by 2033, growing at a CAGR of 11.06% during the forecast period.

The report highlights how a paradigm shift in cancer management-driven by precision medicine, genomics research, and noninvasive testing methods-is unlocking tremendous growth opportunities for stakeholders across the healthcare ecosystem.

Precision Medicine: A Catalyst for Market Growth

Cancer remains one of the leading causes of morbidity and mortality worldwide, prompting healthcare systems to adopt innovative approaches for early detection, monitoring, and treatment. Molecular oncology diagnostics has emerged as a critical enabler of precision medicine-the practice of tailoring treatments based on the molecular profile of each patient's tumor.

Technologies such as nextgeneration sequencing (NGS), polymerase chain reaction (PCR), and in situ hybridization are now standard tools for identifying mutations, guiding targeted therapies, and improving patient outcomes. This personalized approach is fueling demand for robust diagnostic platforms capable of delivering accurate, fast, and actionable results.

Request a Sample [https://bisresearch.com/requestsample?id=2707&type=download&utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr] for Molecular Oncology Diagnostics Market - A Global and Regional Analysis 2024-2034

Key Trends Driving the Market

1. Liquid Biopsy Adoption Liquid biopsy is transforming how cancers are detected and monitored. By analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples, clinicians can detect minimal residual disease (MRD), monitor treatment response, and identify emerging resistance-all without invasive tissue biopsies.

2. Companion Diagnostics Growth Pharmaceutical companies are increasingly pairing targeted therapies with companion diagnostics. This codevelopment model ensures therapies are administered to patients most likely to benefit, improving clinical outcomes and optimizing costs.

3. Technological Innovations Advancements in NGS platforms, multiplex panels, and bioinformatics are expanding the scope of molecular diagnostics, enabling the analysis of multiple genes simultaneously and generating comprehensive molecular profiles.

4. Global Focus on Early Detection Governments and healthcare organizations worldwide are investing in cancer screening programs, which is boosting adoption of advanced molecular tests for early intervention.

Market Segmentation and Opportunities

The BIS Research report segments the market by technology, application, cancer type, end user, and region, offering granular insights for industry stakeholders.

*
By Technology: NGS is projected to lead growth due to its scalability and declining costs. PCR remains vital for routine applications, while fluorescence in situ hybridization (FISH) and microarrays maintain niche roles.

*
By Application: Diagnostics for lung cancer, breast cancer, colorectal cancer, and hematological malignancies remain dominant, with expanding opportunities in rare cancers.

*
By End User: Hospitals and reference laboratories currently account for the largest share, while oncology centers and research institutes are witnessing increased adoption.

Regional Insights

*
North America remains the market leader, supported by strong R&D investments, rapid regulatory approvals, and a mature healthcare infrastructure.

*
Europe is witnessing significant growth driven by stringent diagnostic standards and high awareness of precision medicine.

*
AsiaPacific is expected to register the fastest CAGR due to rising cancer prevalence, expanding healthcare access, and governmentbacked genomics initiatives.

Visit Here for Access Of TOC [https://bisresearch.com/requestsample?id=2707&type=toc]

Implications for Stakeholders

The market's trajectory offers opportunities for a wide spectrum of stakeholders:

*
Diagnostic Manufacturers: Accelerate innovation in NGS and liquid biopsy platforms.

*
Pharmaceutical Companies: Expand companion diagnostic partnerships to enhance targeted therapy pipelines.

*
Healthcare Providers: Integrate molecular testing into clinical workflows to improve patient outcomes.

*
Investors and Consultants: Identify highgrowth segments and emerging players in a dynamic market.

About BIS Research

BIS Research, recognized as a top market research company, specializes in market research reports and advisory services focused on deep technology and emerging trends that are poised to disrupt key industrial markets. Annually, we publish over 200 market intelligence reports across various deep technology verticals.

Our insights support leaders across industries in making informed decisions based on deep market analysis, competitive intelligence, and strategic forecasting. We work closely with innovation-driven stakeholders across data centers, energy & Power, healthcare, and more. We help businesses stay ahead with in-depth reports, custom research [https://bisresearch.com/our-offerings/custom-research?utm_source=Monika&utm_medium=Organic&utm_campaign=abnewswire-pr], and go-to-market strategies [https://info.bisresearch.com/market-entry-strategy?utm_source=Monika&utm_medium=Organic&utm_campaign=abnewswire-pr] tailored to your goals.

Media Contact
Company Name: BIS Research
Contact Person: Bhavya Banga
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-molecular-oncology-diagnostics-market-to-surpass-619-billion-by-2033-driven-by-precision-medicine]
Phone: +1-510-404-8135
Address:39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538
Country: United States
Website: https://bisresearch.com/industry-report/molecular-oncology-diagnostics-market.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Molecular Oncology Diagnostics Market to Surpass $6.19 Billion by 2033, Driven by Precision Medicine here

News-ID: 4108722 • Views:

More Releases from ABNewswire

PRA Public Relations Recognized as Top PR Agency With Multiple Industry Honors
PRA Public Relations Recognized as Top PR Agency With Multiple Industry Honors
Why was PRA Public Relations Recognized as a National Top Tech PR Agency? CEO Pam Abrahamsson Cites a Relentless Dedication to Client Success PRA Public Relations [http://www.prapublicrelations.com/], a national PR agency serving the technology, financial services, and social impact sectors, has announced it was recently recognized with a series of industry honors for its industry knowledge, business-driving results and 'client first' focus. Awards Recognizing PRA Public Relations as a Leading PR Agency
HSNCodeFinder AI Launches Global AI Platform to Simplify Product Classification and HSN Code Search
HSNCodeFinder AI Launches Global AI Platform to Simplify Product Classification …
HSNCodeFinder AI, an innovative SaaS platform, has launched globally to simplify product classification and international trade compliance. This AI-powered HSN Code Finder helps businesses accurately find the correct HSN code for any product in seconds. By automating HSN code search for multiple countries, HSNCodeFinder AI reduces manual errors and ensures smooth customs and tax operations worldwide. October 22, 2025 - HSNCodeFinder AI today announced the launch of its advanced SaaS platform,
Charting the Intelligence Economy: 4 Companies Transforming Market Data (ATHR, TRI, FDS, NDAQ)
Charting the Intelligence Economy: 4 Companies Transforming Market Data (ATHR, T …
In the modern market, information doesn't just guide trades; it is the trade. The distance between reading and reacting has collapsed to milliseconds, and in that blur, data itself has become the most valuable asset on the screen. Artificial intelligence is turning every article, comment, and market signal into a feedback loop of prediction. The result is a new financial ecosystem where algorithms study investors as closely as investors study
Security Matters PLC (NASDAQ: SMX): Turning Waste Into Proof
Security Matters PLC (NASDAQ: SMX): Turning Waste Into Proof
For decades, the world has struggled to turn sustainability promises into measurable results. Recycling programs fell short, industrial polymers went untracked, and plastics remained a liability rather than an asset. Governments set targets, and companies pledged billions, yet the frameworks were never built to succeed. The outcome was predictable: recycling rates stalled, incineration rose, and the promise of a circular economy remained aspirational. That is where SMX (Security Matters, NASDAQ:SMX)

All 5 Releases


More Releases for CAGR

[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064 According to the report published by Allied Market Research,
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032. This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion. These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States. Despite challenges such as training for new